Patent ID: 11859257
Assignee: GEN-PROBE INCORPORATED
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 5:
6. The composition of claim 1, wherein the composition comprises:
(i) an MREJ amplification oligomer configured to specifically hybridize to an MREJ type iv nucleic acid at a site in SEQ ID NO: 4 comprising at least one of positions 545, 551, or 559 of SEQ ID NO: 4;
(ii) at least one MREJ amplification oligomer configured to specifically hybridize to an MREJ type iii nucleic acid at a site in SEQ ID NO: 3 comprising at least one of positions 668, 738, or 750 of SEQ ID NO: 3;
(iii) an MREJ amplification oligomer configured to specifically hybridize to an MREJ type v nucleic acid at a site in SEQ ID NO: 5 comprising position 458 of SEQ ID NO: 5
(iv) an MREJ amplification oligomer configured to specifically hybridize to an MREJ type vi nucleic acid at a site in SEQ ID NO: 6 comprising position 498 or 611 of SEQ ID NO: 6;
(v) an MREJ amplification oligomer configured to specifically hybridize to an MREJ type vii nucleic acid at a site in SEQ ID NO: 7 comprising at least one of positions 563, 565, 601, or 629 of SEQ ID NO: 7;
(vi) an MREJ amplification oligomer configured to specifically hybridize to an MREJ type xii nucleic acid at a site in SEQ ID NO: 9 comprising at least one of positions 617, 624, or 630 of SEQ ID NO: 9;
(vii) an MREJ amplification oligomer is configured to specifically hybridize to an MREJ type xiii nucleic acid at a site in SEQ ID NO: 10 comprising at least one of positions 561, 568, 605, or 628 of SEQ ID NO: 10; and/or
(viii) at least one MREJ amplification oligomer configured to specifically hybridize to an MREJ type xxi nucleic acid at a site in SEQ ID NO: 12 comprising position 461 of SEQ ID NO: 12.